C. Testoni

发表

Endothelium and the brain in CNS lupus

A. Salmaggi, A. Tincani, N. Sepp, 2003, Lupus.

Endothelium as a target for antiphospholipid antibodies.

P. Meroni, M. Gerosa, P. Riboldi, 2003, Immunobiology.

Endothelium activation in the anti-phospholipid syndrome.

P. Meroni, S. Fineschi, M. Borghi, 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.

A. Gabrielli, R. Rezzonico, J. Dayer, 2002, Arthritis and rheumatism.

Interaction of Antiphospholipid Antibodies with Endothelial Cells

P. Meroni, M. Borghi, M. Gerosa, 2006 .

Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome.

F. Nicoletti, E. Tremoli, D. Hess, 2000, Journal of autoimmunity.

Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies.

P. Meroni, M. Borghi, E. Raschi, 2004, Autoimmunity reviews.

Endothelial cell activation by antiphospholipid antibodies.

P. Meroni, M. Borghi, P. Meroni, 2004, Clinical immunology.

Human monoclonal anti-endothelial cell IgG-derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro.

P. Meroni, M. Borghi, A. Patel, 2001, International immunology.

Antiphospholipid/Endothelial Cell Interaction in the Pathogenesis of the Antiphospholipid Syndrome

P. Youinou, A. Tincani, P. Meroni, 2002 .

Antiphospholipid antibodies and the endothelium.

A. Tincani, P. Meroni, E. Raschi, 2001, Rheumatic diseases clinics of North America.

Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitro

P. Meroni, A. Caruso, N. Di Simone, 2004, Annals of the rheumatic diseases.

activation by antiphospholipid antibodies Role of the MYD88 transduction signaling pathway in endothelial

A. Mantovani, T. Koike, P. Meroni, 2013 .

Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies.

A. Mantovani, T. Koike, P. Meroni, 2003, Blood.

Anti-fibroblast antibodies in systemic sclerosis.

N. Ronda, J. Dayer, P. Meroni, 2002, The Israel Medical Association journal : IMAJ.

Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype.

E. Tremoli, M. Khamashta, A. Tincani, 2001, Arthritis and rheumatism.

Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis.

S. Quaglini, C. Ponticelli, A. Tincani, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Functional Heterogeneity of Pathogenic Anti-Endothelial Cell Antibodies

Y. Shoenfeld, P. Meroni, S. Praprotnik, 2001 .

Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway.

N. Ronda, P. Meroni, R. Gatti, 2002, Arthritis and rheumatism.

Endothelium as a target for anti-phospholipid antibodies and for therapeutical intervention.

P. Meroni, E. Raschi, C. Testoni, 2002, Autoimmunity reviews.

Antiphospholipid antibodies as cause of pregnancy loss

P. Meroni, A. Caruso, N. Di Simone, 2004, Lupus.